Clinical Trials Directory

Trials / Conditions / Endocrine Gland Neoplasms

Endocrine Gland Neoplasms

12 registered clinical trials studyying Endocrine Gland Neoplasms — 3 currently recruiting.

StatusTrialSponsorPhase
CompletedNear Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
NCT05152927
University of California, San FranciscoN/A
CompletedAssessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands Duri
NCT05022667
University of MichiganN/A
RecruitingSpanish Series of Patients Treated With the Radionuclide Lutetium177
NCT04949282
Sociedad Española de Medicina Nuclear e Imagen Molecular—
UnknownEfficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian
NCT04556071
Xiaoxiang ChenPhase 2
CompletedEvaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
NCT03717298
Catalysis SLPhase 2
CompletedA Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cance
NCT03535727
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 / Phase 2
CompletedContinuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
NCT02909452
Syndax PharmaceuticalsPhase 1
CompletedCardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
NCT02897778
Syndax PharmaceuticalsPhase 1
CompletedNab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic
NCT01964430
CelgenePhase 3
RecruitingEstablishment of a Tumor Bank for Blood Samples
NCT01763125
Medical University of Vienna—
RecruitingEstablishment of a Tumor Bank for Tissue Samples
NCT01789229
Medical University of Vienna—
CompletedA Study of Trabectedin in Patients With Advanced Ovarian Cancer
NCT00050414
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2